Zimmer Biomet Holdings, Inc. ZBH
91.04
1.35
1.51%
as of 25 Sep
- Market cap
- $17.1B
- P/E
- 22.0×
Follow ZBH
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Zimmer Biomet Holdings, Inc. (ZBH) Total debt
Zimmer Biomet Holdings, Inc.'s total debt at the end of fiscal 2025 was $7.5B, up 21.2% from $6.2B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $7.5B. Over the past ten years it has ranged from $5.7B (fiscal 2022) to $11.5B (fiscal 2015); the current reading is higher than 45% of that period. Zimmer Biomet Holdings, Inc. ranks 6th of 147 Medical Devices companies by total debt.
Total debt, annual
Annual
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $7.5B | 21.19% |
| FY2024 | $6.2B | 7.57% |
| FY2023 | $5.8B | 1.25% |
| FY2022 | $5.7B | (19.41%) |
| FY2021 | $7.1B | (13.02%) |
| FY2020 | $8.1B | (1.15%) |
| FY2019 | $8.2B | (8.02%) |
| FY2018 | $8.9B | (11.87%) |
| FY2017 | $10.1B | (9.78%) |
| FY2016 | $11.2B | (2.23%) |
Quarterly
| Period | Total debt | Change |
|---|---|---|
| Jun 2026 | $7.5B | 0.11% |
| Mar 2026 | $7.5B | (0.64%) |
| Dec 2025 | $7.5B | (7.32%) |
| Sep 2025 | $8.1B | 7.13% |
| 42 more quarters | Free account |
Against its own ten years
Low $5.7B
High $11.5B
Ten-year median
$8.1B
Current reading's percentile
45
Total debt against peers
| Company | Total debt |
|---|---|
| GEHC GE HealthCare Technologies Inc. compare | $11.5B |
| ZBH Zimmer Biomet Holdings, Inc. | $7.5B |
| PHG Koninklijke Philips N.V. compare | $7.3B |
| SNN Smith & Nephew SNATS, Inc. compare | $3.2B |
| STE STERIS plc compare | $1.9B |
| BIO Bio-Rad Laboratories, Inc. compare | $1.2B |
| BIO.B Bio-Rad Laboratories, Inc. compare | $1.2B |
| GMED Globus Medical, Inc. compare | $443.4M |
| PEN Penumbra, Inc. compare | $19.6M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ZBH
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement